From the FMS Global News Desk of Jeanne Hambleton (UK)
Courtesy of FDA/Center for Drug Evaluation and Research
FDA notified healthcare professionals that after an ongoing safety review initiated in February 2008, the manufacturers of licensed botulinum toxin products will be required by FDA to strengthen warnings in product labeling and add a boxed warning regarding [...]
Filed under: 13606, 16816416, 16816701, 18473400, 18473734, 18475482, 18477189, 18477433, 18542595, 18637166, 18638001, 18961528, 19138205, 19555105, 19771093, Article, Awareness, Britain feeds, Brussels feeds, Drugs, Europe feeds, FDA, FM, FMA UK, FMS, FMS Global News, Family, Feeds, Fibrohugs, Fibrohugs News, Fibromyalgia, Fibromyalgia Blogs, Fibromyalgia News, Fibromyalgia News UK, Fibromyalgia Press Releases, Global News, Health, Jeanne Hambleton, Journalist UK, London UK Feed, Medical, Medicine, Michigan feeds, News, News UK, News USA, Pain, Pain 24/7, Pharmacologic, Pharmacological, Quality of Life, RSS, RSS Feeds, Technorati, Tenderpoints, Twitter, UK feeds, US, USA, USA feeds, Washington D.C. City Feed, World, World News, World Wide, World feeds, Worldwide, feed://feedproxy.google.com/bydls, feeds://feedburnercomwordpressmytb-2, http://feedburner.google.com/fb, http://feedburner.google.com/fbX, http://globalhealthvision.wordpress.com, http://jeannehambleton77.wordpress.com, http://www.myspace.com/jeannehambleton | Tagged: aspiration pneumonia, Awareness, Botox, botulinum toxin effects, botulinum toxin products, Britain, cerebral palsy, constipation, difficulty breathing, difficulty swallowing, double vision, drooping eyelids, facial drooping, FDA, FDA warning, feed://feedproxy.google.com/bydls, feeds://feedburnercomwordpressmytb-2, Fibrohugs, Fibrohugs News, Fibromyalgia, Fibromyalgia News UK, Fibromyalgia News. FMS, Fibromyalgia patients, Fibromyalgia Research, Fibromyalgia Support, FM, FMS, FMS Global News, Global Health Vision, Global News, Health, http://feedburner.google.com/fb, Jeanne Hambleton, Journalist UK, London News, Medicine, muscular weakness, News, News UK, ongoing safety review, respiratory depression, risk of adverse events, risks to patients, signal of serious risk, speech disorder, Thoughts, unapproved uses | Leave a Comment »